Advertisement
Shi Huang
Senior Reporter, China
Shi is a science reporter based in Beijing, primarily covering life sciences, medicine, and frontier research. Previously, he worked for Sanlian Lifeweek and DXY.
Shi is a science reporter based in Beijing, primarily covering life sciences, medicine, and frontier research. Previously, he worked for Sanlian Lifeweek and DXY.
Areas of Expertise:
Life science, Medicine Languages Spoken:
English, Mandarin
Researchers use China’s Tianzhou spacecraft missions since 2017 to study how microgravity and space radiation can affect biology.
On his return to China, Zhang says he looks forward to cultivating talent ‘who truly understand science, technology and industrial needs’.
Top planetary scientist will lead young university’s new astronomy department after decades shaping human understanding of the universe.
The robot, nicknamed Surgie, was remotely controlled by human surgeons as it carried out the procedure on a pig.
Advertisement
After a journey including study under luminaries in computer vision and AI sectors, Cao brings Silicon Valley experience to PolyU.
As former faculty vice dean swaps San Diego for Shenzhen, her lab offers jobs, training to researchers interested in sensory signalling.
The compound has a similar chemical structure to ketamine and has been classified as a controlled substance following an upswing in abuse.
Yang looks to cooperation with Europe in areas such as low-carbon technologies, digital energy and emerging sustainable solutions.
District authorities say that only one person was in the two-seater light aircraft at the time of the incident.
Wars and trade saw human genes from East and West fuse as over a million Han dynasty immigrants moved to Ningxia, genomics research reveals.
Award-winning biomedical engineering professor leaves United States to join Nanjing University’s school of biomedical engineering.
New study upends conventional thinking that has blamed Ming’s fall on eunuch dictatorship, factionalism, peasant uprising and rise of Manchus.
The artificial muscles and skin specialist from UCLA will head a physics and engineering institute.
Mainland institutions dominate in 2026, accounting for nine of top 10 in list based on research output in high-quality academic publications.
The physicist who received a fellowship reserved for the ‘brightest young scientists’ in North America has joined Fudan University.
Six weeks of resistance training with a new wearable device more than doubled spinal muscular atrophy patients’ leg strength, study finds.
With the most cases of the two leading neurodegenerative diseases, and affected population rising as country ages, China needs to find new treatments.
Recent discovery provides evidence to support ancient texts about a herbal anaesthetic that was said to have been used during surgery.
The trio faced heightened scrutiny after a former doctoral student and blogger known as Student Geng raised questions about their work.
The acclaimed researcher’s goal is to bring Chinese semiconductor equipment, materials and components up to global standards.
The new system is about 10,000 times more sensitive than traditional methods at detecting early-stage lung cancer.
Prominent young professor becomes doctoral supervisor at leading Chinese research university amid high-level recruitment drive.
Former head of GenAI at Microsoft Asia has focused on machine intelligence in previous research.
Multiple investigations into Chinese researchers at the University of Michigan in recent months involved members of Xu’s laboratory.
Army Medical University researchers issue grim warning after findings show high doses of fish oil tablets may accelerate Alzheimer’s decline.
China’s coastal aquaculture ponds span the largest area in the world but they are shrinking – and that is a good thing.
Talented young scientist’s links with Beihang University raised in recent article but questions remained unanswered.
Original therapy integrating stem cell tech and gene editing could treat a blood disorder with 350 million carriers worldwide.
Chinese biotech firms tackle urgent initiative to create four new pharmaceutical drugs to treat world’s fastest growing form of dementia.
